Condition
Healthy Adult Males
Total Trials
4
Recruiting
0
Active
0
Completed
4
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 4 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 4 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
3Total
Not Applicable (1)
P 1 (2)
Trial Status
Completed4
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 4 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT05691660Phase 1CompletedPrimary
A Study of TAS3731 in Healthy Adults
NCT05396235Phase 1CompletedPrimary
A Clinical Pharmacology Study of MT-3921 in Healthy Adult Males
NCT04887727Not ApplicableCompletedPrimary
Development of Oral Amino Acid Tracers to Study Protein Turnover in Humans
NCT02009917CompletedPrimary
Non- Essential Amino Acid Requirements and Metabolism in Humans
Showing all 4 trials